Is there a role for less invasive therapeutic approaches for low- and intermediate-grade organ-confined prostate cancer?
Sartor
Oliver
O
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001707:Biopsy, Needle; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018426:SEER Program; D014481:United States
D000970:Antineoplastic Agents; D017430:Prostate-Specific Antigen